Literature DB >> 21312021

Ia-like alloantigens in the chicken: Serologic characterization an ontogeny of cellular expression.

D L Ewert1, M D Cooper.   

Abstract

Alloantisera raised in highly inbred lines of chickens, 7(2) and 15I(5) , by reciprocal immunization with lymphocytes were shown by immunofluorescence to react with B cells, cells of the monocyte-macrophage series, and an unidentified population of mononuclear cells prevalent in the spleen and bone marrow. Variable immunogenicity of the 'Ia'(2) and 'Ia'(15) alloantigens was observed. The alloantigens detected by these sara could be redistributed on the B-cell surface independently of immunoglobulin determinants or previously recognized antigens encoded by the major histocompatibility complex (B locus), and were more resistant to proteolysis than slgM. Analysis of several inbred lines of chickens revealed an association between expression of these antigens and the B haplotype. Strains of the B(2) haplotype expressed the antigen detected by anti-7 2 and vice versa. These data suggest that the B-cell alloantigens detected are encoded by genes linked to the MHC and may be analogous to la antigens of mice and DR antigens of man. 'Ia' alleles were co dominantly expressed on lymphocytes of F(1) hybrids. During ontogeny 'a'(+) cells were first detected in the bursa at 10 days of incubation , 3 days before 'Ia'(+). IgM(+) cells could be detected. Both 'Ia'(+).IgM(+) and 'Ia'(+).IgM(-) populations of bursal cells increased in parallel until day 18, when plateau levels were reached. Development of 'Ia'(+).IgM(-) cells throughout the body was unaffected by bursectomy at hatching. Cell surface expression of 'Ia' antigens was apparently increased with B-Iymphocyte maturation and was detectable on most, but not all, mature plasma cells.

Entities:  

Year:  1978        PMID: 21312021     DOI: 10.1007/BF03200422

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  9 in total

1.  MHC-chromosome dosage effects: evidence for increased expression of Ia glycoprotein and alteration of B cell subpopulations in neonatal aneuploid chickens.

Authors:  M E Delany; R R Dietert; S E Bloom
Journal:  Immunogenetics       Date:  1988       Impact factor: 2.846

2.  Biochemical confirmation of recombination within the B-G subregion of the chicken major histocompatibility complex.

Authors:  M M Miller; R Goto; W E Briles
Journal:  Immunogenetics       Date:  1988       Impact factor: 2.846

Review 3.  Structure and properties of the major histocompatibility complex of the chicken. Speculations on the advantages and evolution of polymorphism.

Authors:  B M Longenecker; T R Mosmann
Journal:  Immunogenetics       Date:  1981       Impact factor: 2.846

4.  Evidence for two populations of B-L (Ia-like) molecules encoded by the chicken MHC.

Authors:  M Crone; J Jensenius; C Koch
Journal:  Immunogenetics       Date:  1981       Impact factor: 2.846

Review 5.  Major histocompatibility complex of chickens: genes, antigens, differential features, and special contributions to our knowledge of the advantages of polymorphism of cell surface antigens.

Authors:  B M Longenecker
Journal:  Surv Immunol Res       Date:  1982

6.  Relationship between the expression of class I antigen and reactivity of chicken thymocytes.

Authors:  R Sgonc; K Hála; G Wick
Journal:  Immunogenetics       Date:  1987       Impact factor: 2.846

7.  AT-1.1: a thymus-specific alloantigen of chickens.

Authors:  A T Waytes; L D Bacon; N R Rose
Journal:  Immunogenetics       Date:  1984       Impact factor: 2.846

8.  B-L antigens (class II) of the chicken major histocompatibility complex control T-B cell interaction.

Authors:  O Vainio; C Koch; A Toivanen
Journal:  Immunogenetics       Date:  1984       Impact factor: 2.846

9.  Genetics of Ia-like alloantigens in chickens and linkage with B major histocompatibility complex.

Authors:  D L Ewert; D G Gilmour; W E Briles; M D Cooper
Journal:  Immunogenetics       Date:  1980       Impact factor: 2.846

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.